Relationship between serum lipoprotein(a) concentrations and coronary vasomotion in coronary spastic angina

Circulation Journal

Volumn 69, Issue 5, 2005, Pages 521-525

  Tsuchida, Keiichi ^a   Hori, Tomoyuki ^a   Tanabe, Naohito ^a   Makiyama, Yashiro ^a   Ozawa, Takuya ^a   Saigawa, Takashi ^a   Watanabe, Ritsuo ^a   Tanaka, Takayuki ^a   Nasuno, Akimitsu ^a   Fukunaga, Hiroshi ^a   Mezaki, Tohru ^a   Nakamura, Yuichi ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Basal coronary artery tone; Coronary spastic angina; Ergonovine; Lipoprotein(a)

Indexed keywords

ERGOMETRINE; ISOSORBIDE DINITRATE; LIPOPROTEIN A; NITRIC OXIDE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY RISK; DIABETES MELLITUS; DISEASE ACTIVITY; FEMALE; GENDER; HUMAN; HYPERTENSION; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RIGHT CORONARY ARTERY; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY VASOSPASM; CORONARY VESSELS; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; VASODILATION;

EID: 21144481712     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.521     Document Type: Article

References (32)

1. Berg K. A new serum type system in man: The Lp system. Acta Pathol Microbiol Scand 1963; 59: 369-382.
2. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease: Meta-analysis of prospective studies. Circulation 2000; 102: 1082-1085.
3. Djurovic S, Berg K. Epidemiology of Lp(a) lipoprotein: Its role in atherosclerotic/thrombotic disease. Clin Genet 1997; 52: 281-292.
4. Igarashi Y, Aizawa Y, Satoh T, Konno T, Ojima K, Aizawa Y. Predictor of adverse long-term outcome in acute myocardial infarction patients undergoing primary percutaneous transluminal coronary angioplasty: With special reference to the admission concentration of lipoprotein(a). Circ J 2003; 67: 605-611.
5. Tsurumi Y, Nagashima H, Ichikawa KI, Sumiyoshi T, Hosoda S. Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol 1995; 26: 1242-1250.
6. Schachinger V, Halle M, Minners J, Berg A, Zeiher AM. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol 1997; 30: 927-934.
7. Ioka T, Tasaki H, Yashiro A, Yamashita K, Ozumi K, Tsutsui M, et al. Association between plasma lipoprotein(a) and endothelial dysfunction in normocholesterolemic and non-diabetic patients with angiographically normal coronary arteries. Circ J 2002; 66: 267-271.
8. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963.
9. Waters DD, Szlachcic J, Bonan R, Miller DD, Dauwe F, Theroux P. Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 1983; 67: 310-315.
10. Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986; 74: 1255-1265.
11. Bory M, Panagides D, Desfossez L. Coronary artery spasm in myocardial infarction. Lancet 1993; 342: 436.
12. Igarashi Y, Tamura Y, Suzuki K, Tanabe Y, Yamaguchi T, Fujita T, et al. Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. Coron Artery Dis 1993; 4: 177-185.
13. Igarashi Y, Yamazoe M, Suzuki K, Tamura Y, Matsubara T, Tanabe Y, et al. Possible role of coronary artery spasm in unexplained syncope. Am J Cardiol 1990; 65: 713-717.
14. Nobuyoshi M, Abe M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, et al. Statistical analysis of clinical risk factors for coronary artery spasm: Identification of the most important determinant. Am Heart J 1992; 124: 32-38.
15. Miwa K, Nakagawa K, Yoshida N, Taguchi Y, Inoue H. Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J Am Coll Cardiol 2000; 35: 1200-1205.
16. World Health Organization. Diabetes mellitus: Report of a WHO study group. Geneva. World Health Organization, 1985; WHO Tech Rep Ser no. 727.
17. Teramoto T, Yamada N, Shimano H, Oka Y, Itakura H, Saito Y, et al. Dose-dependent effect of niceritrol on plasma lipoprotein-a. Scand J Clin Lab Invest 1996; 56: 359-365.
18. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al. The Atherosclerosis Risk in Communities Study Investigators: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069-1075.
19. Haines CJ, Chung T, Masarei J, Tomlinson B, Lau J. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins. Atherosclerosis 1996; 119: 215-222.
20. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996; 27: 1-25.
21. Igarashi Y, Yamazoe M, Shibata A. Effect of direct intracoronary administration of methylergonovine in patients with and without variant angina. Am Heart J 1991; 121: 1094-1100.
22. Hori T, Matsubara T, Ishibashi T, Ozaki K, Tsuchida K, Mezaki T, et al. Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina. Circ J 2003; 67: 305-311.
23. Lipid Research Clinic Program. Lipid and lipoprotein analysis: Manual of Laboratory Operations. Washington DC: US Government Printing Office, 1982; US Dept Health, Education, and Welfare publication NIH/75-628.
24. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. Utterman G. The mysteries of lipoprotein(a). Science 1989; 249: 904-910.
26. Tatineni S, Kem MJ, Deligonul U, Aguirre F. The effect of ionic and non-ionic radiographic contrast media on coronary hyperemia in patients during coronary angiography. Am Heart J 1992; 123: 621-627.
27. Kuga T, Egashira K, Iou T, Takeshita A. Correlation of basal coronary artery tone with constrictive response to ergonovine in patients with variant angina. J Am Coll Cardiol 1993; 22: 144-150.
28. Previtali M, Panciroli C, Ponti RD, Chimienti M, Montemartini C, Salerno JA. Time-related decrease in sensitivity to ergonovine in patients with variant angina. Am Heart J 1989; 117: 92-99.
29. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
30. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993; 88: 43-54.
31. Hori T, Matsubara T, Ishibashi T, Yamazoe M, Ida T, Higuchi K, et al. Decrease of nitric oxide end-products during coronary circulation reflects elevated basal coronary artery tone in patients with vasospastic angina. Jpn Heart J 2000; 41: 583-595.
32. Schlaich MP, John S, Langenfeld MRW, Lackner KJ, Schmitz G, Schmieder RE. Does lipoprotein(a) impair endothelial function? J Am Coll Cardiol 1998; 31: 359-365.